EIRGENIX INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.6 TWD | +0.62% |
|
+5.43% | -18.81% |
ETFs positioned on EirGenix Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 117 M€ | -0.14% | - | |
| 0.00% | 34 M€ | +1.32% | - |
EirGenix Inc is a Taiwan-based company primarily engaged in the development of antibody drugs and the manufacture of biopharmaceuticals. Its main businesses include the provision of Contract Development & Manufacturing Organization (CDMO) services, the construction of cell strain, the manufacture of clinical trial medicine, analytical science and protein identification, and PIC/S manufacturing plant to provide clinical trial drug production.
Sector
Pharmaceuticals
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
81.6
TWD
Average target price
132.5
TWD
Spread / Average Target
+62.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.81% | 766M | |
| -3.63% | 86.85B | |
| +2.76% | 40.16B | |
| -16.48% | 31.28B | |
| +57.86% | 25.27B | |
| -13.58% | 15.33B | |
| -9.12% | 11.96B | |
| -42.56% | 11.61B | |
| +6.89% | 8.83B | |
| -8.19% | 7.94B |
- Stock Market
- Equities
- 6589 Stock
- Funds and ETFs EirGenix Inc.
